| High performance plasma amyloid-β biomarkers for Alzheimer’s disease A Nakamura, N Kaneko, VL Villemagne, T Kato, J Doecke, V Doré, ... Nature 554 (7691), 249-254, 2018 | 1674 | 2018 |
| Blood-based protein biomarkers for diagnosis of Alzheimer disease JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ... Archives of neurology 69 (10), 1318-1325, 2012 | 485 | 2012 |
| Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment L Cheng, JD Doecke, RA Sharples, VL Villemagne, CJ Fowler, ... Molecular psychiatry 20 (10), 1188-1196, 2015 | 398 | 2015 |
| Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease X Hadoux, F Hui, JKH Lim, CL Masters, A Pébay, S Chevalier, J Ha, S Loi, ... Nature communications 10 (1), 4227, 2019 | 246 | 2019 |
| Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals N Fandos, V Pérez-Grijalba, P Pesini, S Olmos, M Bossa, VL Villemagne, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 8, 179-187, 2017 | 207 | 2017 |
| The relationship between sleep quality and brain amyloid burden BM Brown, SR Rainey-Smith, VL Villemagne, M Weinborn, RS Bucks, ... Sleep 39 (5), 1063-1068, 2016 | 177 | 2016 |
| Plasma amyloid-β as a biomarker in Alzheimer's disease: the AIBL study of aging JK Lui, SM Laws, QX Li, VL Villemagne, D Ames, B Brown, AI Bush, ... Journal of Alzheimer's disease 20 (4), 1233-1242, 2010 | 169 | 2010 |
| Validation of plasma amyloid-β 42/40 for detecting Alzheimer disease amyloid plaques Y Li, SE Schindler, JG Bollinger, V Ovod, KG Mawuenyega, MW Weiner, ... Neurology 98 (7), e688-e699, 2022 | 165 | 2022 |
| Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease A Rembach, NG Faux, AD Watt, KK Pertile, RL Rumble, BO Trounson, ... Alzheimer's & Dementia 10 (1), 53-61, 2014 | 160 | 2014 |
| Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis JD Doecke, V Pérez-Grijalba, N Fandos, C Fowler, VL Villemagne, ... Neurology 94 (15), e1580-e1591, 2020 | 158 | 2020 |
| An anemia of Alzheimer's disease NG Faux, A Rembach, J Wiley, KA Ellis, D Ames, CJ Fowler, RN Martins, ... Molecular psychiatry 19 (11), 1227-1234, 2014 | 153 | 2014 |
| Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: a cross‐sectional and longitudinal study in the AIBL cohort P Chatterjee, S Pedrini, JD Doecke, R Thota, VL Villemagne, V Doré, ... Alzheimer's & Dementia 19 (4), 1117-1134, 2023 | 131 | 2023 |
| Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian … NG Faux, KA Ellis, L Porter, CJ Fowler, SM Laws, RN Martins, KK Pertile, ... Journal of Alzheimer's Disease 27 (4), 909-922, 2011 | 124 | 2011 |
| Thermal imaging of soybean response to drought stress: the effect of Ascophyllum nodosum seaweed extract A Martynenko, K Shotton, T Astatkie, G Petrash, C Fowler, W Neily, ... Springerplus 5, 1-14, 2016 | 122 | 2016 |
| Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) study: progress and observations from 2,359 older adults spanning the spectrum from cognitive normality … C Fowler, SR Rainey-Smith, S Bird, J Bomke, P Bourgeat, BM Brown, ... Journal of Alzheimer's disease reports 5 (1), 443-468, 2021 | 110 | 2021 |
| Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease K Dhiman, VB Gupta, VL Villemagne, D Eratne, PL Graham, C Fowler, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 100 | 2020 |
| Association of β-amyloid and apolipoprotein E ε4 with memory decline in preclinical Alzheimer disease YY Lim, P Kalinowski, RH Pietrzak, SM Laws, SC Burnham, D Ames, ... JAMA neurology 75 (4), 488-494, 2018 | 97 | 2018 |
| ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes A Soldan, C Pettigrew, AM Fagan, SE Schindler, A Moghekar, C Fowler, ... Neurology 92 (14), e1567-e1579, 2019 | 95 | 2019 |
| Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing SR Rainey-Smith, Y Gu, SL Gardener, JD Doecke, VL Villemagne, ... Translational psychiatry 8 (1), 238, 2018 | 87 | 2018 |
| Decreased plasma iron in Alzheimer’s disease is due to transferrin desaturation DJ Hare, JD Doecke, NG Faux, A Rembach, I Volitakis, CJ Fowler, ... ACS chemical neuroscience 6 (3), 398-402, 2015 | 83 | 2015 |
